SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001610618-21-000012
Filing Date
2021-02-25
Accepted
2021-02-25 17:26:47
Documents
4
Effectiveness Date
2021-02-25
Reference 429
333-236874

Document Format Files

Seq Description Document Type Size
1 FORM S-8 cdtxs-82021x02x25.htm S-8 95743
2 CONSENT OF COOLEY LLP exhibit512021-02x25.htm EX-5.1 9528
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit2312021-12sx8.htm EX-23.1 2733
4 image21.jpg GRAPHIC 38052
  Complete submission text file 0001610618-21-000012.txt   159923
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253545 | Film No.: 21681926
SIC: 2836 Biological Products, (No Diagnostic Substances)